Chronic Myeloproliferative Disorders Completed Phase 1 Trials for Motexafin gadolinium (DB05428)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00036790Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerTreatment